Transaction · 0001764013-26-000110

Venker Eric

Venker Eric, CEO, reported an open-market or private sale at Immunovant, Inc. involving 3506.000000 shares for an estimated $119589.66. Reported holdings after the transaction were 257075.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
IMVTImmunovant, Inc.
Filing timeOct 05
Trade dateOct 02, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded1.35%Shares sold ÷ (holdings after + shares sold). Estimated position before: 260,581 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$33.29
Pre-filing
1mo ago +18.6%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

IMVT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IMVT since 2026-10-05Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001764013-26-000110
Common Stock
Transaction date
Oct 02, 2026
Filed Oct 05, 2026, 11:42 PM · 3d delay
Shares
3.50k sh
$34.11 per share
Estimated value
-$119k
Computed from shares × price
Holdings after
257k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a…

  2. F2

    On October 1, 2026, the Service Requirement (as defined in Footnote 4), Performance Requirement (as defined in Footnote 4), Knock-In Requirement (as defined in Footnote 4), and hurdle price applicable…

  3. F3

    The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated…

  4. F4

    These CVARs vest on the first date that each of (i) the Service Requirement, (ii) the Performance Requirement, and (iii) the Knock-in Requirement have been satisfied. The "Service Requirement" is sati…

Original filing · 0001764013-26-000110
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IMVT